These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 14996642

  • 1. Avinza - 24-h sustained-release oral morphine therapy.
    Caldwell JR.
    Expert Opin Pharmacother; 2004 Feb; 5(2):469-72. PubMed ID: 14996642
    [Abstract] [Full Text] [Related]

  • 2. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.
    J Opioid Manag; 2006 Feb; 2(3):155-66. PubMed ID: 17319449
    [Abstract] [Full Text] [Related]

  • 3. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study.
    Rosenthal M, Moore P, Groves E, Iwan T, Schlosser LG, Dziewanowska Z, Negro-Vilar A.
    J Opioid Manag; 2007 Feb; 3(3):145-54. PubMed ID: 18027540
    [Abstract] [Full Text] [Related]

  • 4. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
    Portenoy RK, Sciberras A, Eliot L, Loewen G, Butler J, Devane J.
    J Pain Symptom Manage; 2002 Apr; 23(4):292-300. PubMed ID: 11997198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK, Cherry DA, Onley MM, Tordoff SG, Conn DA, Hood GM, Plummer JL.
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.
    Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, Yuan W, Eliot L, Babul N, Lynch PM.
    J Pain Symptom Manage; 2002 Apr; 23(4):278-91. PubMed ID: 11997197
    [Abstract] [Full Text] [Related]

  • 8. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK.
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [Abstract] [Full Text] [Related]

  • 9. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y, Iseki M.
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Avinza Elan.
    Semenchuk MR.
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1369-72. PubMed ID: 12498014
    [Abstract] [Full Text] [Related]

  • 12. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW, Goughnour BR, White JA, Stewart JH.
    CMAJ; 1989 Mar 15; 140(6):653-7, 661. PubMed ID: 2645988
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B, Ross E, Sasaki J, Weil A.
    Curr Med Res Opin; 2006 Aug 15; 22(8):1503-14. PubMed ID: 16870075
    [Abstract] [Full Text] [Related]

  • 14. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun 15; 12(65):83-4. PubMed ID: 12825566
    [Abstract] [Full Text] [Related]

  • 15. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
    Adams EH, Chwiecko P, Ace-Wagoner Y, Mangefrida B, Duerden ME, Perdikis GC, Kunkel FA, Ghalie R.
    Pain Pract; 2006 Dec 15; 6(4):254-64. PubMed ID: 17129306
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP, Sloan PA, Maroun JA, Boos GJ, Besner JG, Stewart JH, Mount BM.
    Cancer; 1989 Jun 01; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D, Sopata M, Burneckis A, Jespersen L, Andersen C.
    J Pain Symptom Manage; 2010 Apr 01; 39(4):712-20. PubMed ID: 20413058
    [Abstract] [Full Text] [Related]

  • 18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Apr 01; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 19. A comparison of regularly administered sustained release oral morphine with intramuscular morphine for control of postoperative pain.
    Bourke M, Hayes A, Doyle M, McCarroll M.
    Anesth Analg; 2000 Feb 01; 90(2):427-30. PubMed ID: 10648333
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
    Cundiff D, McCarthy K, Savarese JJ, Kaiko R, Thomas G, Grandy R, Goldenheim P.
    Cancer; 1989 Jun 01; 63(11 Suppl):2355-9. PubMed ID: 2720581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.